Posted by Michael Wonder on 10 May 2022
FDA launches new Accelerating Rare disease Cures (ARC) program
10 May 2022 - FDA’s Center for Drug Evaluation and Research (CDER) is pleased to announce the launch of the new Accelerating Rare disease Cures (ARC) Program.
The Agency intends for the CDER ARC Program to speed and increase the development of effective and safe treatment options addressing the unmet needs of patients with rare diseases.
